Medicine and Dentistry
Crohn's Disease
91%
Inflammatory Bowel Disease
88%
Ulcerative Colitis
60%
Cohort Analysis
49%
Patient with Inflammatory Bowel Disease
38%
Patient with Crohn's Disease
31%
Quality of Life
29%
Fecal Microbiota Transplantation
28%
Disease
28%
Capsule Endoscopy
27%
Disease Activity
26%
Biological Therapy
25%
Tumor Necrosis Factor
24%
Placebo
18%
Patient with Ulcerative Colitis
17%
Infliximab
17%
Psoriatic Arthritis
16%
Randomized Controlled Trial
15%
Diagnostic Accuracy
15%
Biological Marker
15%
Diagnosis
14%
Infection
14%
TNF Inhibitor
13%
C Reactive Protein
13%
Faecal Calprotectin
13%
Inflammatory Disorder
12%
Irritable Bowel Syndrome
11%
Hazard Ratio
11%
Hereditary Hemorrhagic Telangiectasia
11%
Disease Course
11%
Health Care Cost
10%
Combination Therapy
9%
Drug Therapy
9%
Personalized Medicine
9%
Mucosa
8%
Ileocolonoscopy
8%
Elderly Patient
8%
COVID-19
8%
Biological Product
7%
Colon
7%
Primary Health Care
7%
Computed Tomography Enterography
7%
Mesalazine
7%
Ileo-Anal Pouch
6%
Odds Ratio
6%
Immunomodulating Agent
6%
Calgranulin
6%
Endoscopy
6%
Maintenance Therapy
6%
Pouchitis
6%
Pharmacology, Toxicology and Pharmaceutical Science
Crohn's Disease
100%
Inflammatory Bowel Disease
94%
Ulcerative Colitis
68%
Cohort Study
50%
Disease Activity
34%
Infliximab
33%
Disease
30%
Feces microflora
22%
Tumor Necrosis Factor
22%
Psoriatic Arthritis
20%
Biological Marker
20%
Tumor Necrosis Factor Inhibitor
19%
Infection
19%
Placebo
18%
Calgranulin
13%
Inflammatory Disease
13%
Remission
12%
Biological Product
10%
Aminosalicylic Acid
10%
C Reactive Protein
10%
Irritable Colon
9%
Adalimumab
9%
Immunomodulating Agent
8%
Rendu Osler Weber Disease
8%
Combination Therapy
7%
Inflammation
7%
Dicarbonate
7%
Randomized Controlled Trial
7%
Inflammatory Arthritis
6%
Wound Healing
6%
Prothrombin
6%
Mercaptopurine
5%
Rheumatoid Arthritis
5%
Vedolizumab
5%
Leukotriene B4
5%
Congenital Blood Vessel Malformation
5%
Prednisolone
5%
Anticoagulant Agent
5%
Prevalence
5%
Colitis
5%
Disease Course
5%
Dextran Sulfate
5%
Immunology and Microbiology
Crohn's Disease
67%
Ulcerative Colitis
54%
Inflammatory Bowel Disease
53%
Infliximab
25%
Inflammatory Disorder
21%
Psoriatic Arthritis
13%
Extracellular Matrix
11%
Feces microflora
11%
Colitis
10%
Basement Membrane
10%
Tumor Necrosis Factor
10%
Wound Healing
9%
Biological Product
9%
Inflammatory Arthritis
7%
Normal Human
7%
Blood Plasma
7%
Prednisolone
6%
C-Reactive Protein
5%
Laminin
5%
Drug Dose Intensification
5%
T Cell
5%
Adolescence
5%
TNF Inhibitor
5%
Adalimumab
5%
